Llinks Advised Shanghai Kaibao on Public Offering and Listing on ChiNext

Shanghai Kaibao Pharmaceutical Co., Ltd's public offering of 27,400,000 ordinary shares was approved by the China Securities Regulatory Commission on December 4, 2009. The amount of funds raised from this public offering is approximately RMB 1 billion.

As legal counsel to Shanghai Kaibao, Llinks advised on all aspects of this public offering and listing on ChiNext.